AUROLOGISTICS supplier risk profile Q1-2026: pharma importer with India-concentrated sourcing and watchlist matches.
AUROLOGISTICS processed 135 shipments in Q1 2026 across 10 suppliers in three countries. India accounted for 73.3% of shipment volume, followed by Sri Lanka at 23.7%. The company sources primarily from Aurobindo Pharma and APL Health Care entities, with shipments classified under HS Chapter 30 (pharmaceutical products). The concentrated supplier base reflects a narrow product focus within the pharmaceutical sector.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
AUROLOGISTICS shows two names matching sanctions watchlists during Q1 2026. No suppliers in the sourcing network register exposure under the Uyghur Forced Labor Prevention Act framework.
10 distinct tier-1 suppliers in Q1 2026
| APL HEALTH CARE SEZ UNIT 4 | Sri Lanka | 32 |
| AUROBINDO PHARMA | India | 32 |
| AUROBINDO PHARMA UNIT 7 | India | 31 |
| APL HEALTH CARE UNIT 01 | India | 17 |
| AUROBINDO PHARMA UNIT 12 | India | 10 |
| APL HEALTHCARE | India | 4 |
| APL HEALTH CARE SEZ UNIT 4 | Spain | 4 |
| APL HEALTH CARE | India | 3 |
Share of Q1 2026 inbound shipments by source country
4 tier-2 + 13 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.